Bottom line
Is RSINX a good fund? The bottom line
RSINX is the Class A share class of Victory RS Investors Fund, a managed large blend mutual fund from Victory Capital.
Its expense ratio is 1.33% — about $133 a year on every $10,000 invested, more expensive than 78% of large blend funds we track.
It returned +0.3% over one year, +11.1% a year over five years, +9.4% a year over ten (as of Dec 31, 2025, per its prospectus).
With $71.2 million in net assets and 30 holdings, its largest position is Globe Life Inc. (6.7%) and the top 10 make up 43.6% of the portfolio.
This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.
What to watch
- Expensive for its category (1.33%)
- Front-end sales load up to 5.75%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What RSINX invests in
The Victory RS Investors Fund (the Fund) seeks to provide long-term capital appreciation.
The Adviser pursues the Funds investment objective by investing, under normal circumstances, in equity securities that the Funds investment team believes are undervalued. The Fund invests in equity securities of small-, mid-, or large-capitalization companies. The Fund typically invests in equity securities of U.S. companies but may also invest any portion of its assets in foreign securities, including depositary receipts such as American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). The Fund is non-diversified and expects to hold a larger portion of its assets in a smaller number of issuers. As a result of the Advisers investment process, the Funds investments may be focused in one or more economic sectors from time to time, including the financials sector. In evaluating investments for the Fund, the Adviser conducts fundamental research to identify companies with…
From the fund's prospectus (filed Apr 29, 2026).
RSINX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| RSINX | +0.3% | +11.1% | +9.4% |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2025
What RSINX costs
On a $10,000 investment, RSINX's 1.33% expense ratio costs about $133 a year. The prospectus estimates $2,316 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
RSINX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Globe Life Inc. | 6.66% |
| 2 | The St. Joe Company | 4.79% |
| 3 | Cvs Health Corporation | 4.37% |
| 4 | Apple Inc. | 4.06% |
| 5 | Citigroup Inc. | 4.04% |
| 6 | Plains Gp Holdings, L.p | 4.02% |
| 7 | Amazon.com, Inc. | 4.01% |
| 8 | The Timken Company | 3.91% |
| 9 | The Cigna Group | 3.89% |
| 10 | Unum Group | 3.86% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 43.6% of the fund. See all top 25 holdings and asset mix →